Illumine Investment Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.24M	Buy	9,879 +238	+2%	+$29.9K	0.99%	36
2025 Q1	$1.07M	Buy	9,641 +139	+1%	+$15.4K	0.87%	40
2024 Q4	$1.3M	Buy	+9,502	New	+$1.3M	1.07%	37